Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Core EBITDA Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 15.41-20.02-3.593.8626.35

What is the latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH ?

The latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH is 15.41 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202615.41
Mar2025-20.02
Mar2024-3.59
Mar20233.86
Mar202226.35

How is Core EBITDA Growth of MEDICAMEN BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2026 15.41
Positive
Mar2025 -20.02
Negative
Mar2024 -3.59
Negative
Mar2023 3.86
-85.35
Mar2022 26.35 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Core EBITDA Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹375.0 Cr -2.5% -17.9% -20.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -0.1% -6.5% 3.8% Stock Analytics
DIVIS LABORATORIES ₹240,780.0 Cr -0.2% -5.5% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,828.0 Cr 0.4% -8.2% 25.2% Stock Analytics
CIPLA ₹109,305.0 Cr 1.7% -2% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,759.0 Cr 4.9% 7.7% -2.5% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-2.5%

-17.9%

-20.1%

SENSEX

-1.5%

-1.2%

-11.8%


You may also like the below Video Courses